The advent and application of high-resolution array-based comparative genome hybridization (array CGH) has led to the detection of large numbers of copy number variants (CNVs) in patients with developmental delay and/or multiple congenital anomalies as well as in healthy individuals. The notion that CNVs are also abundantly present in the normal population challenges the interpretation of the clinical significance of detected CNVs in patients. In this review we will illustrate a general clinical workflow based on our own experience that can be used in routine diagnostics for the interpretation of CNVs.

Keywords:
Array analysis, Array CGH, Benign CNV, Diagnostics, Interpretation, Pathogenic CNV
1.
Barber JC: Directly transmitted unbalanced chromosome abnormalities and euchromatic variants. J Med Genet 42:609–629 (2005).
2.
Bijlsma EK, Gijsbers AC, Schuurs-Hoeijmakers JH, van Haeringen A, Fransen van de Putte DE, et al: Extending the phenotype of recurrent rearrangements of 16p11.2: deletions in mentally retarded patients without autism and in normal individuals. Eur J Med Genet 52:77–87 (2009).
3.
Buysse K, Delle Chiaie B, Van Coster R, Loeys B, De Paepe A, et al: Challenges for CNV interpretation in clinical molecular karyotyping: lessons learned from a 1001 sample experience. Eur J Med Genet 52:398–403 (2009a).
4.
Buysse K, Reardon W, Mehta L, Costa T, Fagerstrom C, et al: The 12q14 microdeletion syndrome: additional patients and further evidence that HMGA2 is an important genetic determinant for human height. Eur J Med Genet 52:101–107 (2009b).
5.
Brothman AR, Schneider NR, Saikevych I, Cooley LD, Butler MG, et al: Cytogenetic heteromorphisms: survey results and reporting practices of Giemsa-band regions that we have pondered for years. Arch Pathol Lab Med 130:947–949 (2006).
6.
Bruno DL, Anderlid BM, Lindstrand A, van Ravenswaaij-Arts C, Ganesamoorthy D, et al: Further molecular and clinical delineation of co-locating 17p13.3 microdeletions and microduplications that show distinctive phenotypes. J Med Genet 47:299–311 (2010).
7.
Bruno DL, Ganesamoorthy D, Schoumans J, Bankier A, Coman D, et al: Detection of cryptic pathogenic copy number variations and constitutional loss of heterozygosity using high resolution SNP microarray analysis in 117 patients referred for cytogenetic analysis and impact on clinical practice. J Med Genet 46:123–131 (2009).
8.
Castermans D, Thienpont B, Volders K, Crepel A, Vermeesch JR, et al: Position effect leading to haploinsufficiency in a mosaic ring chromosome 14 in a boy with autism. Eur J Hum Genet 16:1187–1192 (2008).
9.
Coman DJ, Gardner RJ: Deletions that reveal recessive genes. Eur J Hum Genet 15:1103–1104 (2007).
10.
Cook DL, Gerber AN, Tapscott SJ: Modeling stochastic gene expression: implications for haploinsufficiency. Proc Natl Acad Sci USA 95:15641–15646 (1998).
11.
de Smith AJ, Tsalenko A, Sampas N, Scheffer A, Yamada NA, et al: Array CGH analysis of copy number variation identifies 1284 new genes variant in healthy white males: implications for association studies of complex diseases. Hum Mol Genet 16:2783–2794 (2007).
12.
Edelmann L, Pandita RK, Spiteri E, Funke B, Goldberg R, et al: A common molecular basis for rearrangement disorders on chromosome 22q11. Hum Mol Genet 8:1157–1167 (1999).
13.
Firth HV, Richards SM, Bevan AP, Clayton S, Corpas M, et al: DECIPHER: Database of chromosomal imbalance and phenotype in humans using ensembl resources. Am J Hum Genet 84:524–533 (2009).
14.
Flipsen-ten Berg K, van Hasselt PM, Eleveld MJ, van der Wijst SE, Hol FA, et al: Unmasking of a hemizygous WFS1 gene mutation by a chromosome 4p deletion of 8.3 Mb in a patient with Wolf-Hirschhorn syndrome. Eur J Hum Genet 15:1132–1138 (2007).
15.
Gijsbers AC, Lew JY, Bosch CA, Schuurs-Hoeijmakers JH, van Haeringen A, et al: A new diagnostic workflow for patients with mental retardation and/or multiple congenital abnormalities: test arrays first. Eur J Hum Genet 17:1394–1402 (2009).
16.
Girirajan S, Rosenfeld JA, Cooper GM, Antonacci F, Siswara P, et al: A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay. Nat Genet 42:203–209 (2010).
17.
Itsara A, Wu H, Smith JD, Nickerson DA, Romieu I, et al: De novo rates and selection of large copy number variation. Genome Res 20:1469–1481 (2010).
18.
Knijnenburg J, Oberstein SA, Frei K, Lucas T, Gijsbers AC, et al: A homozygous deletion of a normal variation locus in a patient with hearing loss from non-consanguineous parents. J Med Genet 46:412–417 (2009).
19.
Koolen DA, Pfundt R, de Leeuw N, Hehir-Kwa JY, Nillesen WM, et al: Genomic microarrays in mental retardation: a practical workflow for diagnostic applications. Hum Mutat 30:283–292 (2009).
20.
Lee C, Iafrate AJ, Brothman AR: Copy number variations and clinical cytogenetic diagnosis of constitutional disorders. Nat Genet 39:S48-S54 (2007).
21.
Lejeune J, Gautier M, Turpin R: Etude des chromosomes somatiques de neuf enfants mongoliens. C R Acad Sci 248:1721–1722 (1959).
22.
McCarroll SA, Kuruvilla FG, Korn JM, Cawley S, Nemesh J, et al: Integrated detection and population-genetic analysis of SNPs and copy number variation. Nat Genet 40:1166–1174 (2008).
23.
Menten B, Maas N, Thienpont B, Buysse K, Vandesompele J, et al: Emerging patterns of cryptic chromosomal imbalance in patients with idiopathic mental retardation and multiple congenital anomalies: a new series of 140 patients and review of published reports. J Med Genet 43:625–633 (2006).
24.
Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, et al: Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 86:749–764 (2010).
25.
Nowakowska B, de Leeuw N, Ruivenkamp CAL, Sikkema-Raddatz B, Crolla JA, et al: Parental insertional balanced translocations are an important cause of apparently de novo CNVs in patients with developmental anomalies. Eur J Hum Genet in press (2011).
26.
Perry GH, Ben-Dor A, Tsalenko A, Sampas N, Rodriguez-Revenga L, et al: The fine-scale and complex architecture of human copy-number variation. Am J Hum Genet 82:685–695 (2008).
27.
Poot M, Hochstenbach R: A three-step workflow procedure for the interpretation of array-based comparative genome hybridization results in patients with idiopathic mental retardation and congenital anomalies. Genet Med 12:478–485 (2010).
28.
Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, et al: Global variation in copy number in the human genome. Nature 444:444–454 (2006).
29.
Rossetti S, Kubly VJ, Consugar MB, Hopp K, Roy S, et al: Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease. Kidney Int 75:848–855 (2009).
30.
Schinzel A: Catalogue of Unbalanced Chromosome Aberrations in Man, 2nd ed. (de Gruyter, Berlin 2001).
31.
Slavotinek AM: Novel microdeletion syndromes detected by chromosome microarrays. Hum Genet 124:1–17 (2008).
32.
Van Esch H, Backx L, Pijkels E, Fryns JP: Congenital diaphragmatic hernia is part of the new 15q24 microdeletion syndrome. Eur J Med Genet 52:153–156 (2009).
33.
Van Vooren S, Coessens B, De Moor B, Moreau Y, Vermeesch JR: Array comparative genomic hybridization and computational genome annotation in constitutional cytogenetics: suggesting candidate genes for novel submicroscopic chromosomal imbalance syndromes. Genet Med 99:642–649 (2007).
34.
Walters RG, Jacquemont S, Valsesia A, de Smith AJ, Martinet D, et al: A new highly penetrant form of obesity due to deletions on chromosome 16p11.2. Nature 463:671–675 (2010).
35.
Whitby H, Tsalenko A, Aston E, Tsang P, Mitchell S, et al: Benign copy number changes in clinical cytogenetic diagnostics by array CGH. Cytogenet Genome Res 123:94–101 (2008).
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.